Last 12 months
Inside the activity.
1 purchase rows · 20 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 13 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 3 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 15, 2026 Filed Jan 16, 2026 21:30 UTC |
Roy SumitDirector
|
GrantCommon Stock | 68.063 | $76.92 | $5,235.41 |
DisclosureSEC source: 0001529329-26-000006 · wk-form4_1768599037.xml · nonDerivative · entry 2 Roy Sumit · CIK 0001529329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,859.714 F3 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on January 15, 2026. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:30 UTC |
Roy SumitDirector
|
GrantCommon Stock | 48.195 | $76.92 | $3,707.16 |
DisclosureSEC source: 0001529329-26-000006 · wk-form4_1768599037.xml · nonDerivative · entry 1 Roy Sumit · CIK 0001529329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,791.651 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on January 15, 2026. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Plan. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:30 UTC |
Rodriguez Joe Vasquez Jr.Director
|
GrantCommon Stock | 42.037 | $76.92 | $3,233.49 |
DisclosureSEC source: 0002014328-26-000002 · wk-form4_1768599034.xml · nonDerivative · entry 1 Rodriguez Joe Vasquez Jr. · CIK 0002014328 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,806.498 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on January 15, 2026. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:30 UTC |
NADER MARGUERITE MDirector
|
GrantCommon Stock | 68.063 | $76.92 | $5,235.41 |
DisclosureSEC source: 0001356681-26-000002 · wk-form4_1768599030.xml · nonDerivative · entry 1 NADER MARGUERITE M · CIK 0001356681 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,358.216 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on January 15, 2026. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:30 UTC |
LUSTIG MATTHEW JDirector
|
GrantCommon Stock | 68.063 | $76.92 | $5,235.41 |
DisclosureSEC source: 0001203367-26-000006 · wk-form4_1768599021.xml · nonDerivative · entry 2 LUSTIG MATTHEW J · CIK 0001203367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,266.446 F3 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on January 15, 2026. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:30 UTC |
LUSTIG MATTHEW JDirector
|
GrantCommon Stock | 231.163 | $76.92 | $17,781.06 |
DisclosureSEC source: 0001203367-26-000006 · wk-form4_1768599021.xml · nonDerivative · entry 1 LUSTIG MATTHEW J · CIK 0001203367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,198.383 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on January 15, 2026. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Plan. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:30 UTC |
Martino Roxanne MDirector
|
GrantCommon Stock | 187.938 | $76.92 | $14,456.19 |
DisclosureSEC source: 0001676558-26-000004 · wk-form4_1768599025.xml · nonDerivative · entry 1 Martino Roxanne M · CIK 0001676558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,267.777 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on January 15, 2026. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Plan. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:30 UTC |
EMBLER MICHAEL JDirector
|
GrantCommon Stock | 68.063 | $76.92 | $5,235.41 |
DisclosureSEC source: 0001209170-26-000002 · wk-form4_1768599018.xml · nonDerivative · entry 1 EMBLER MICHAEL J · CIK 0001209170 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,588.216 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on January 15, 2026. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| January 15, 2026 Filed Jan 16, 2026 21:30 UTC |
Barnes Melody CDirector
|
GrantCommon Stock | 68.063 | $76.92 | $5,235.41 |
DisclosureSEC source: 0001619369-26-000002 · wk-form4_1768599014.xml · nonDerivative · entry 1 Barnes Melody C · CIK 0001619369 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,193.216 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Equity Award Deferral Program (the "Program") adopted pursuant to the Ventas, Inc. 2022 Incentive Plan as a result of dividend equivalents credited with respect to the dividend on Issuer's common stock paid on January 15, 2026. Such units are payable solely in common stock and subject to the terms and conditions of the Reporting Person's deferral election and the Program. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:51 UTC |
Smith Maurice SDirector
|
GrantCommon Stock | 484.935 | $77.33 | $37,500.02 |
DisclosureSEC source: 0001841752-26-000003 · wk-form4_1767739886.xml · nonDerivative · entry 1 Smith Maurice S · CIK 0001841752 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,966.806 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:50 UTC |
Martino Roxanne MDirector
|
GrantCommon Stock | 662.744 | $77.33 | $51,249.99 |
DisclosureSEC source: 0001676558-26-000002 · wk-form4_1767739850.xml · nonDerivative · entry 1 Martino Roxanne M · CIK 0001676558 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,079.839 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:51 UTC |
Roy SumitDirector
|
GrantCommon Stock | 404.112 | $77.33 | $31,249.98 |
DisclosureSEC source: 0001529329-26-000004 · wk-form4_1767739865.xml · nonDerivative · entry 1 Roy Sumit · CIK 0001529329 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,743.456 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:50 UTC |
LUSTIG MATTHEW JDirector
|
GrantCommon Stock | 420.277 | $77.33 | $32,500.02 |
DisclosureSEC source: 0001203367-26-000004 · wk-form4_1767739832.xml · nonDerivative · entry 1 LUSTIG MATTHEW J · CIK 0001203367 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 91,967.22 F1 · shares: Common stock in the form of units granted under the Ventas, Inc. Non-Employee Directors' Cash Compensation Deferral Plan (the "Plan") in lieu of director fees pursuant to the director's deferral election. Such units are payable solely in common stock and subject to the terms and conditions of the director's deferral election and the Plan. F2 · price: Represents the closing price per share of Issuer's common stock as of the grant date. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:50 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,322 | $0.00 Strike: $73.71 | $0.00 |
DisclosureSEC source: 0001215188-26-000002 · wk-form4_1767739817.xml · derivative · entry 4 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,644 Underlying: Common Stock · 10,322 shares Expires 2026-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 8 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F5 · derivative.exercise_date: Fully vested. F6 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:50 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Tax withholdingCommon Stock | 7,900 | $77.33 | $610,907.00 |
DisclosureSEC source: 0001215188-26-000002 · wk-form4_1767739817.xml · nonDerivative · entry 3 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,137,795 F3 · shares: Represents shares withheld to pay taxes on the vesting of restricted stock units granted to the Reporting Person on March 19, 2025 under the Ventas, Inc. 2022 Incentive Plan. F4 · price: Represents the applicable closing price per share of Issuer's common stock as of the date of the vesting. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:50 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
SaleCommon Stock | 10,322 | $77.26 | $797,474.62 |
DisclosureSEC source: 0001215188-26-000002 · wk-form4_1767739817.xml · nonDerivative · entry 2 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,145,695 F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 8 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $76.7835 to $77.66, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:50 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 10,322 | $73.71 | $760,834.62 |
DisclosureSEC source: 0001215188-26-000002 · wk-form4_1767739817.xml · nonDerivative · entry 1 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,156,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 8 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:49 UTC |
Roberts Carey S.EVP and GC
|
Tax withholdingCommon Stock | 1,609 | $77.33 | $124,423.97 |
DisclosureSEC source: 0001720831-26-000002 · wk-form4_1767739780.xml · nonDerivative · entry 1 Roberts Carey S. · CIK 0001720831 · EVP and GC 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,041 F1 · shares: Represents shares withheld to pay taxes on the vesting of restricted stock units granted to the Reporting Person on March 19, 2025 under the Ventas, Inc. 2022 Incentive Plan. F2 · price: Represents the applicable closing price per share of Issuer's common stock as of the date of the vesting. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:49 UTC |
Probst Robert FEVP and CFO
|
Tax withholdingCommon Stock | 2,275 | $77.33 | $175,925.75 |
DisclosureSEC source: 0001531510-26-000002 · wk-form4_1767739795.xml · nonDerivative · entry 2 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 136,159 F3 · shares: Represents shares withheld to pay taxes on the vesting of restricted stock units granted to the Reporting Person on March 19, 2025 under the Ventas, Inc. 2022 Incentive Plan. F4 · price: Represents the applicable closing price per share of Issuer's common stock as of the date of the vesting. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:49 UTC |
Probst Robert FEVP and CFO
|
SaleCommon Stock | 29,930 | $77.25 | $2,312,188.28 |
DisclosureSEC source: 0001531510-26-000002 · wk-form4_1767739795.xml · nonDerivative · entry 1 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 138,434 F1 · shares: Transaction is pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025. F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $76.73 to $77.66 inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:49 UTC |
Hutchens James JustinEVP Senior Housing and CIO
|
Tax withholdingCommon Stock | 2,043 | $77.33 | $157,985.19 |
DisclosureSEC source: 0001410715-26-000002 · wk-form4_1767739764.xml · nonDerivative · entry 1 Hutchens James Justin · CIK 0001410715 · EVP Senior Housing and CIO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 167,049 F1 · shares: Represents shares withheld to pay taxes on the vesting of restricted stock units granted to the Reporting Person on March 19, 2025 under the Ventas, Inc. 2022 Incentive Plan. F2 · price: Represents the applicable closing price per share of Issuer's common stock as of the date of the vesting. Read SEC document |
| January 02, 2026 Filed Jan 6, 2026 22:49 UTC |
Bulgarelli Peter J.EVP OM&R-Ventas/Pres&CEO-LHS
|
Tax withholdingCommon Stock | 1,676 | $77.33 | $129,605.08 |
DisclosureSEC source: 0001736887-26-000002 · wk-form4_1767739748.xml · nonDerivative · entry 1 Bulgarelli Peter J. · CIK 0001736887 · EVP OM&R-Ventas/Pres&CEO-LHS 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 104,812 F1 · shares: Represents shares withheld to pay taxes on the vesting of restricted stock units granted to the Reporting Person on March 19, 2025 under the Ventas, Inc. 2022 Incentive Plan. F2 · price: Represents the applicable closing price per share of Issuer's common stock as of the date of the vesting. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 21:05 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,322 | $0.00 Strike: $73.71 | $0.00 |
DisclosureSEC source: 0001215188-25-000014 · wk-form4_1764795925.xml · derivative · entry 3 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 30,966 Underlying: Common Stock · 10,322 shares Expires 2026-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F3 · derivative.exercise_date: Fully vested. F4 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 21:05 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
SaleCommon Stock | 10,322 | $80.55 | $831,418.52 |
DisclosureSEC source: 0001215188-25-000014 · wk-form4_1764795925.xml · nonDerivative · entry 2 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,145,695 F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $80.13 to $80.81, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| December 01, 2025 Filed Dec 3, 2025 21:05 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 10,322 | $73.71 | $760,834.62 |
DisclosureSEC source: 0001215188-25-000014 · wk-form4_1764795925.xml · nonDerivative · entry 1 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,156,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. Read SEC document |
| November 19, 2025 Filed Nov 20, 2025 21:30 UTC |
Bulgarelli Peter J.EVP OM&R-Ventas/Pres&CEO-LHS
|
SaleCommon Stock | 2,229 | $80.08 | $178,504.34 |
DisclosureSEC source: 0001736887-25-000006 · wk-form4_1763674249.xml · nonDerivative · entry 2 Bulgarelli Peter J. · CIK 0001736887 · EVP OM&R-Ventas/Pres&CEO-LHS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 106,488 F1 · shares: Transaction is pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 20, 2025. F3 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $79.99 to $80.2441, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 21:30 UTC |
Bulgarelli Peter J.EVP OM&R-Ventas/Pres&CEO-LHS
|
SaleCommon Stock | 2,771 | $80.01 | $221,700.51 |
DisclosureSEC source: 0001736887-25-000006 · wk-form4_1763674249.xml · nonDerivative · entry 1 Bulgarelli Peter J. · CIK 0001736887 · EVP OM&R-Ventas/Pres&CEO-LHS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 108,717 F1 · shares: Transaction is pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 20, 2025. F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $79.99 to $80.20, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 21:34 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 41,294 | $0.00 Strike: $73.71 | $0.00 |
DisclosureSEC source: 0001215188-25-000012 · wk-form4_1763588076.xml · derivative · entry 3 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,288 Underlying: Common Stock · 41,294 shares Expires 2026-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F3 · derivative.exercise_date: Fully vested. F4 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 21:34 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
SaleCommon Stock | 41,294 | $79.01 | $3,262,535.71 |
DisclosureSEC source: 0001215188-25-000012 · wk-form4_1763588076.xml · nonDerivative · entry 2 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,145,695 F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $79.00 to $79.1703, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 17, 2025 Filed Nov 19, 2025 21:34 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 41,294 | $73.71 | $3,043,780.74 |
DisclosureSEC source: 0001215188-25-000012 · wk-form4_1763588076.xml · nonDerivative · entry 1 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,186,989 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 22:13 UTC |
Probst Robert FEVP and CFO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 33,591 | $0.00 Strike: $73.71 | $0.00 |
DisclosureSEC source: 0001531510-25-000004 · wk-form4_1763158435.xml · derivative · entry 3 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 33,591 shares Expires 2026-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025. F3 · derivative.exercise_date: Fully vested. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 22:13 UTC |
Probst Robert FEVP and CFO
|
SaleCommon Stock | 33,591 | $76.77 | $2,578,844.89 |
DisclosureSEC source: 0001531510-25-000004 · wk-form4_1763158435.xml · nonDerivative · entry 2 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 168,364 F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025. F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $76.71 to $76.9376 inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 12, 2025 Filed Nov 14, 2025 22:13 UTC |
Probst Robert FEVP and CFO
|
Exercise / conversionCommon Stock | 33,591 | $73.71 | $2,475,992.61 |
DisclosureSEC source: 0001531510-25-000004 · wk-form4_1763158435.xml · nonDerivative · entry 1 Probst Robert F · CIK 0001531510 · EVP and CFO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 201,955 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 9 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 19, 2025. Read SEC document |
| November 07, 2025 Filed Nov 12, 2025 11:01 UTC |
Bulgarelli Peter J.EVP OM&R-Ventas/Pres&CEO-LHS
|
SaleCommon Stock | 40 | $75.70 | $3,028.05 |
DisclosureSEC source: 0001736887-25-000004 · wk-form4_1762945280.xml · nonDerivative · entry 1 Bulgarelli Peter J. · CIK 0001736887 · EVP OM&R-Ventas/Pres&CEO-LHS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,488 F1 · shares: Transaction is pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 20, 2025. F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $75.26 to $76.14, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 06, 2025 Filed Nov 6, 2025 23:50 UTC |
Bulgarelli Peter J.EVP OM&R-Ventas/Pres&CEO-LHS
|
SaleCommon Stock | 166 | $75.15 | $12,475.48 |
DisclosureSEC source: 0000740260-25-000281 · wk-form4_1762473037.xml · nonDerivative · entry 3 Bulgarelli Peter J. · CIK 0001736887 · EVP OM&R-Ventas/Pres&CEO-LHS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,528 F1 · shares: Transaction is pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 20, 2025. F4 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $75.01 to $75.39, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 06, 2025 Filed Nov 6, 2025 23:50 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 264 | $0.00 Strike: $63.24 | $0.00 |
DisclosureSEC source: 0000740260-25-000279 · wk-form4_1762472999.xml · derivative · entry 9 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,582 Underlying: Common Stock · 264 shares Expires 2026-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 12 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F5 · derivative.exercise_date: Fully vested. F6 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person. Read SEC document |
| November 06, 2025 Filed Nov 6, 2025 23:50 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
SaleCommon Stock | 264 | $75.05 | $19,812.91 |
DisclosureSEC source: 0000740260-25-000279 · wk-form4_1762472999.xml · nonDerivative · entry 6 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,145,695 F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 12 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F4 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $75.03 to $75.25, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 06, 2025 Filed Nov 6, 2025 23:50 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 264 | $63.24 | $16,695.36 |
DisclosureSEC source: 0000740260-25-000279 · wk-form4_1762472999.xml · nonDerivative · entry 5 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,145,959 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 12 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. Read SEC document |
| November 05, 2025 Filed Nov 6, 2025 23:50 UTC |
Bulgarelli Peter J.EVP OM&R-Ventas/Pres&CEO-LHS
|
SaleCommon Stock | 870 | $75.28 | $65,493.95 |
DisclosureSEC source: 0000740260-25-000281 · wk-form4_1762473037.xml · nonDerivative · entry 2 Bulgarelli Peter J. · CIK 0001736887 · EVP OM&R-Ventas/Pres&CEO-LHS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,694 F1 · shares: Transaction is pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 20, 2025. F3 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $74.99 to $75.5623, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 05, 2025 Filed Nov 6, 2025 23:50 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 19,250 | $0.00 Strike: $63.24 | $0.00 |
DisclosureSEC source: 0000740260-25-000279 · wk-form4_1762472999.xml · derivative · entry 8 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,846 Underlying: Common Stock · 19,250 shares Expires 2026-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 12 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F5 · derivative.exercise_date: Fully vested. F6 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person. Read SEC document |
| November 05, 2025 Filed Nov 6, 2025 23:50 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
SaleCommon Stock | 19,250 | $75.29 | $1,449,347.90 |
DisclosureSEC source: 0000740260-25-000279 · wk-form4_1762472999.xml · nonDerivative · entry 4 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,145,695 F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 12 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F3 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $75.00 to $75.61, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 05, 2025 Filed Nov 6, 2025 23:50 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 19,250 | $63.24 | $1,217,370.00 |
DisclosureSEC source: 0000740260-25-000279 · wk-form4_1762472999.xml · nonDerivative · entry 3 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,164,945 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 12 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 23:50 UTC |
Bulgarelli Peter J.EVP OM&R-Ventas/Pres&CEO-LHS
|
SaleCommon Stock | 3,924 | $75.00 | $294,286.66 |
DisclosureSEC source: 0000740260-25-000281 · wk-form4_1762473037.xml · nonDerivative · entry 1 Bulgarelli Peter J. · CIK 0001736887 · EVP OM&R-Ventas/Pres&CEO-LHS 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 112,564 F1 · shares: Transaction is pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on February 20, 2025. F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $74.99 to $75.11, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 23:50 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 11,452 | $0.00 Strike: $63.24 | $0.00 |
DisclosureSEC source: 0000740260-25-000279 · wk-form4_1762472999.xml · derivative · entry 7 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 102,096 Underlying: Common Stock · 11,452 shares Expires 2026-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 12 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F5 · derivative.exercise_date: Fully vested. F6 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 23:50 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
SaleCommon Stock | 11,452 | $75.02 | $859,147.36 |
DisclosureSEC source: 0000740260-25-000279 · wk-form4_1762472999.xml · nonDerivative · entry 2 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,145,695 F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 12 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F2 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $75.00 to $75.15, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 04, 2025 Filed Nov 6, 2025 23:50 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 11,452 | $63.24 | $724,224.48 |
DisclosureSEC source: 0000740260-25-000279 · wk-form4_1762472999.xml · nonDerivative · entry 1 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,157,147 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 12 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. Read SEC document |
| November 03, 2025 Filed Nov 3, 2025 23:56 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,322 | $0.00 Strike: $63.24 | $0.00 |
DisclosureSEC source: 0001215188-25-000008 · wk-form4_1762214203.xml · derivative · entry 18 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 113,548 Underlying: Common Stock · 10,322 shares Expires 2026-11-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 13 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F11 · derivative.exercise_date: Fully vested. F12 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person. Read SEC document |
| November 03, 2025 Filed Nov 3, 2025 23:56 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 10,322 | $0.00 Strike: $73.71 | $0.00 |
DisclosureSEC source: 0001215188-25-000008 · wk-form4_1762214203.xml · derivative · entry 17 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 123,870 Underlying: Common Stock · 10,322 shares Expires 2026-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 10 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F11 · derivative.exercise_date: Fully vested. F12 · balance_after: Represents total number of unexercised options to purchase shares of Issuer's Common Stock held by the Reporting Person. Read SEC document |
| November 03, 2025 Filed Nov 3, 2025 23:56 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
SaleCommon Stock | 10,322 | $73.74 | $761,095.77 |
DisclosureSEC source: 0001215188-25-000008 · wk-form4_1762214203.xml · nonDerivative · entry 12 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,145,695 F5 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 13 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. F10 · price: The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $72.86 to $74.17, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| November 03, 2025 Filed Nov 3, 2025 23:56 UTC |
CAFARO DEBRA ADirector · Chairman and CEO
|
Exercise / conversionCommon Stock | 10,322 | $63.24 | $652,763.28 |
DisclosureSEC source: 0001215188-25-000008 · wk-form4_1762214203.xml · nonDerivative · entry 11 CAFARO DEBRA A · CIK 0001215188 · Director · Chairman and CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,156,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · shares: The transaction involved the exercise of fully vested options scheduled to expire in the next 13 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 28, 2024. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.